Article Information
History
- February 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Seon Kyeong Park1,*,
- Young June Choe2,*,
- Seung Ah Choe3,
- Benjamin John Cowling4,
- Ji Hae Hwang1,
- Ju Hee Lee1,
- Kil Hun Lee1,
- Seonju Yi1,
- Sang Won Lee1,
- Geun-Yong Kwon1,
- Eun Jung Jang1,
- Ryu Kyung Kim1 and
- Young-Joon Park1,†
- 1Director for Epidemiological Investigation Analysis, Korea Disease Control and Prevention Agency, Cheongju, Korea
- 2Department of Pediatrics, Korea University Anam Hospital, and Allergy and Immunology Center, Korea University, Seoul, Korea
- 3Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea
- 4WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong
- ↵†Correspondence:
Young-Joon Park, MD, MPH. Director for Epidemiological Investigation Analysis, Korea Disease Control and Prevention Agency, Osong Health Technology Administration Complex, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Korea. Email: pahmun{at}korea.kr
↵* Equally contributed to the manuscript
Posted February 19, 2023.
Comparative Effectiveness of BNT162b2 and NVX-CoV2373 Vaccines in Korean Adults
